Atlas Trials

Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia

Clinical trial NCT01960387 · TERMINATED

Trial details

NCT number
NCT01960387
Sponsor
University of Pittsburgh
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2013-10-01
Primary completion
2015-03-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.